BFEC
SYRS

Benjamin F. Edwards & Company’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Benjamin F. Edwards & Company’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-17
Closed -$2K – 1600
2017
Q3 		$2K Buy
+17
New +$2K ﹤0.01% 1427